Latest News

High adverse events with TB prevention in HIV-infected pregnant women


 

FROM CROI 2018

“I think we now need to reweigh the evidence for pros and cons for IPT in pregnancy,” Dr. Gupta concluded.

The study was sponsored the National Institutes of Health. Dr. Gupta reported having nothing to disclose.

SOURCE: Gupta A et al. CROI 2018, Abstract Number 142LB.

Pages

Recommended Reading

FDA approves new combination drug for HIV patients
MDedge Family Medicine
Gut-homing protein predicts HIV-acquisition, disease progression in women
MDedge Family Medicine
Inflammatory markers predict vaccine response in HCV, HIV
MDedge Family Medicine
VIDEO: The return of Kaposi’s sarcoma
MDedge Family Medicine
Bloating. Flatulence. Think SIBO
MDedge Family Medicine
One-month TB-prevention regimen effective in HIV+ individuals
MDedge Family Medicine
Hair tracks HIV antiretroviral adherence
MDedge Family Medicine
FDA approves new treatment for multidrug-resistant HIV
MDedge Family Medicine
Looking to increase PrEP uptake
MDedge Family Medicine
Efavirenz-based ART may hamper vaginal ring contraception
MDedge Family Medicine